Detalhe da pesquisa
1.
VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.
J Virol
; 88(9): 4897-907, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24554655
2.
C peptides as entry inhibitors for gene therapy.
Adv Exp Med Biol
; 848: 191-209, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25757622
3.
A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity.
Antimicrob Agents Chemother
; 57(2): 679-88, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23147734
4.
Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection.
Mol Ther
; 19(7): 1236-44, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21364540
5.
Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46.
J Virol
; 83(10): 4844-53, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19279116
6.
Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy.
Mol Ther Oncolytics
; 3: 16021, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27738655